Publications

Beeson, William, Kyle Gabriel, Christopher Cornelison. 2023. Fungi as a source of eumelanin: current understanding and prospects. Journal of Industrial Microbiology and Biotechnology.

Gabriel, Kyle T., Ashley G. McDonald, Kelly E. Lutsch, Peter E. Pattavina, Katrina M. Morris, Emily A. Ferrall, Sidney A. Crow, Jr., Christopher T. Cornelison. 2022. Development of a multi-year white-nose syndrome mitigation strategy using antifungal volatile organic compounds. PLoS ONE.

Parker, Ryan A., Kyle T. Gabriel, Kayla D. Graham, Bethany K. Butts, Christopher T. Cornelison. 2022. Antifungal Activity of Select Essential Oils against Candida auris and Their Interactions with Antifungal Drugs. Pathogens.

Lutsch, Kelly E., Ashley G. McDonald, Kyle T. Gabriel, Christopher T. Cornelison. 2021. Roadway-associated culverts may serve as a transmission corridor for Pseudogymnoascus destructans and white-nose syndrome in the coastal plains and coastal region of Georgia, USA. Journal of Wildlife Diseases.

Parker, Ryan A., Kyle T. Gabriel, Kayla Graham, Christopher T. Cornelison. 2019. Validation of methylene blue viability staining with the emerging pathogen Candida auris. Journal of Microbiological Methods.

Gabriel, Kyle T., John J. Neville, George E. Pierce, Christopher T. Cornelison. 2019. Lipolytic Activity and the Utilization of Fatty Acids Associated with Bat Sebum by Pseudogymnoascus destructans. Mycopathologia.

Hussein, Emad I., Jacob H. Jacob, Muhamad Ali K. Shakhatreh, Mutaz A. Abd Al-Razaq, Abdul-Salam F. Juhmani, Christopher T. Cornelison. 2018. Detection of antibiotic-producing Actinobacteria in the sediment and water of Ma'in thermal springs (Jordan). GERMS 8(4):191-198. doi: 10.18683/germs.2018.1146.

Gabriel, Kyle T., Leila Kartforosh, Sidney A. Crow Jr., Christopher T. Cornelison. 2018. Antimicrobial Activity of Essential Oils Against the Fungal Pathogens Ascosphaera apis and Pseudogymnoascus destructans. Mycopathologia 183(6): 921-934.

Jacob, Jacob H., Emad I. Hussein, Muhamad Ali K. Shakhatreh, Mutaz A. Abd Al-Razaq, Abdul-Salam F. Juhmani, Ala'a I. Matalka, Christopher T. Cornelison. 2018. High-Throughput Sequencing-Based Review of Bacillus Diversity in Jordanian Hot Springs Water. World Applied Sciences Journal 36 (3): 470-475.

Gabriel, Kyle T., D. Joseph Sexton, Christopher T. Cornelison. 2018. Biomimicry of volatile-based microbial control for managing emerging fungal pathogens. Journal of Applied Microbiology 124:1024–1031.

Hussein, Emad I., Jacob H. Jacob, Muhamad Ali K. Shakhatreh, Mutaz A. Abd Al-razaq, Abdul-salam F. Juhmani, Christopher T. Cornelison. 2017. Exploring the microbial diversity in Jordanian hot springs by comparative metagenomic analysis. MicrobiologyOpen.

Jacob, Jacob H., Emad I. Hussein, Muhamad Ali K. Shakhatreh, Christopher T. Cornelison. 2017. Microbial community analysis of the hypersaline water of the Dead Sea using high-throughput amplicon sequencing. MicrobiologyOpen.

Cornelison, Christopher T., Blake Cherney, Kyle T. Gabriel, Courtney K. Barlament, and Sidney A. Crow Jr. 2016. Contact-Independent Antagonism of Ophidiomyces ophiodiicola, the Causative Agent of Snake Fungal Disease by Rhodococcus rhodochrous DAP 96253 and Select Volatile Organic Compounds. Journal of Veterinary Science & Technology 7.

Cornelison, C.T., K.M. Keel, K.T. Gabriel, C.K. Barlament, T.A. Tucker, G.E. Pierce, and S.A. Crow Jr. 2014. A preliminary report on the contact-independent antagonism of Pseudogymnoascus destructans by Rhodococcus rhodochrous strain DAP96253. BMC Microbiology. 14:246.

Cornelison, C.T., K.T. Gabriel, C.K. Barlament, and S.A. Crow Jr. 2013. Inhibition of Pseudogymnoascus destructans growth from conidia and mycelial extension by bacterially produced volatile organic compounds. Mycopathologia. 177(1-2):1-10.

Cornelison, C.T. The Enemy of my Enemy is my Friend, A new hope in the battle against WNS? Bats Magazine. Summer, 2013. (32)1:2-4. PDF, Text.

Cornelison, C.T., B. Stubblefield, E. Gilbert, and S.A. Crow Jr. 2012. Recurrent Aspergillus contamination in a biomedical research facility: a case study. J. Ind. Microbiol. Biotechnol. (39)2:329-335.

©